BioSpace News Archive

Press Releases

Quanterix Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - September 16, 2026

September 17, 2026
·
1 min read
Press Releases

Roche’s Lunsumio-based regimen significantly improves progression-free survival in follicular lymphoma in phase III CELESTIMO study

September 17, 2026
·
7 min read
Press Releases

Genentech’s Lunsumio-Based Regimen Significantly Improves Progression-Free Survival in Follicular Lymphoma in Phase III CELESTIMO Study

September 17, 2026
·
15 min read
Press Releases

Innate Pharma Reports First Half 2026 Business Update and Financial Results

September 17, 2026
·
20 min read
Press Releases

Boehringer Ingelheim launches PED Essentials, an online learning resource that gives patients a stronger voice

September 17, 2026
·
4 min read
Press Releases

Tarja Stenvall Appointed Chief Executive Officer of Bavarian Nordic

September 17, 2026
·
5 min read
Press Releases

Vicore Pharma to Present in The Stifel 2026 Virtual Immunology and Inflammation Forum

September 17, 2026
·
1 min read
Press Releases

Merz Therapeutics Receives EU/EEA Approval for XEOMIN® for the Treatment of Pediatric Spasticity Associated With Pes Equinus

September 17, 2026
·
4 min read
Press Releases

Akeso’s EGFR/TROP2 Bispecific ADC AK158D1 Granted NMPA Phase I Clearance for Advanced Solid Tumors, Marking Its Fourth Clinical-Stage ADC Candidate

September 17, 2026
·
6 min read
Press Releases

Bayer’s KERENDIA® (finerenone) Receives FDA Approval as the First New Treatment in 30 Years for Adults with Chronic Kidney Disease (CKD) and Type 1 Diabetes

September 17, 2026
·
15 min read